Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ratjen

Showing results (261-270 of 326) with videos related to

Pageof 33
Sort By:
Pediatric Pulmonology|November 15, 2008
Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosisHarriet Corvol, Pierre-Yves Boelle, Jacques Brouard, et al.
The European Respiratory Journal|December 22, 2019
Normative data for multiple breath washout outcomes in school-aged Caucasian childrenPinelopi Anagnostopoulou, Philipp Latzin, Renee Jensen, et al.
Thorax|April 30, 2021
Time to get serious about the detection and monitoring of early lung disease in cystic fibrosisKatie J Bayfield, Tonia A Douglas, Tim Rosenow, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 12, 2023
Effects of elexacaftor/tezacaftor/ivacaftor therapy in children with cystic fibrosis - a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRICarmen Streibel, Corin C Willers, Orso Pusterla, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2014
European Cystic Fibrosis Society Standards of Care: Best Practice guidelinesAlan R Smyth, Scott C Bell, Snezana Bojcin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2021
Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-studyScott H Donaldson, Beth L Laube, Peter Mogayzel, et al.
Pediatric Pulmonology|May 24, 2018
Reference equations for the interpretation of forced expiratory and plethysmographic measurements in infantsZihang Lu, Rachel E Foong, Krzysztof Kowalik, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 11, 2024
Same-Day Repeatability and 28-Day Reproducibility of Xenon MRI Ventilation in Children With Cystic Fibrosis in a Multi-Site TrialLaura L Walkup, David J Roach, Joseph W Plummer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 28, 2023
Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trialYuxin Chen, Qianting Lv, Eleni-Rosalina Andrinopoulou, et al.
Journal of Clinical Medicine|December 9, 2023
Reply to Eker et al. Comment on "Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. <i>J. Clin. Med.</i> 2023, <i>12</i>, 2704"Alexandra Kilian, Giuseppe A Latino, Andrew J White, et al.
Pageof 33

Showing results (261-270 of 326) with videos related to

Sort By:
Pageof 33
Pediatric Pulmonology|November 15, 2008
Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosisHarriet Corvol, Pierre-Yves Boelle, Jacques Brouard, et al.
The European Respiratory Journal|December 22, 2019
Normative data for multiple breath washout outcomes in school-aged Caucasian childrenPinelopi Anagnostopoulou, Philipp Latzin, Renee Jensen, et al.
Thorax|April 30, 2021
Time to get serious about the detection and monitoring of early lung disease in cystic fibrosisKatie J Bayfield, Tonia A Douglas, Tim Rosenow, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 12, 2023
Effects of elexacaftor/tezacaftor/ivacaftor therapy in children with cystic fibrosis - a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRICarmen Streibel, Corin C Willers, Orso Pusterla, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2014
European Cystic Fibrosis Society Standards of Care: Best Practice guidelinesAlan R Smyth, Scott C Bell, Snezana Bojcin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2021
Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-studyScott H Donaldson, Beth L Laube, Peter Mogayzel, et al.
Pediatric Pulmonology|May 24, 2018
Reference equations for the interpretation of forced expiratory and plethysmographic measurements in infantsZihang Lu, Rachel E Foong, Krzysztof Kowalik, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 11, 2024
Same-Day Repeatability and 28-Day Reproducibility of Xenon MRI Ventilation in Children With Cystic Fibrosis in a Multi-Site TrialLaura L Walkup, David J Roach, Joseph W Plummer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 28, 2023
Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trialYuxin Chen, Qianting Lv, Eleni-Rosalina Andrinopoulou, et al.
Journal of Clinical Medicine|December 9, 2023
Reply to Eker et al. Comment on "Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. <i>J. Clin. Med.</i> 2023, <i>12</i>, 2704"Alexandra Kilian, Giuseppe A Latino, Andrew J White, et al.
Pageof 33